Found: 15
Select item for more details and to access through your institution.
The Diagnosis and Treatment of Tuberculosis.
- Published in:
- Deutsches Ärzteblatt International, 2019, v. 116, n. 43, p. 729, doi. 10.3238/arztebl.2019.0729
- By:
- Publication type:
- Article
Immune response to mRNA‐based COVID‐19 booster vaccination in people living with HIV.
- Published in:
- HIV Medicine, 2023, v. 24, n. 7, p. 785, doi. 10.1111/hiv.13481
- By:
- Publication type:
- Article
Gasdermin D mediates host cell death but not interleukin-1β secretion in Mycobacterium tuberculosis-infected macrophages.
- Published in:
- Cell Death Discovery, 2021, v. 7, n. 1, p. 1, doi. 10.1038/s41420-021-00716-5
- By:
- Publication type:
- Article
Postoperative granulomatous peritonitis mimicking abdominal tuberculosis.
- Published in:
- Clinical Case Reports, 2018, v. 6, n. 9, p. 1810, doi. 10.1002/ccr3.1724
- By:
- Publication type:
- Article
Effective high-throughput RT-qPCR screening for SARS-CoV-2 infections in children.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-30664-2
- By:
- Publication type:
- Article
Optimizing Antiretroviral Therapy in Heavily ART-Experienced Patients with Multi-Class Resistant HIV-1 Using Proviral DNA Genotypic Resistance Testing.
- Published in:
- Viruses (1999-4915), 2023, v. 15, n. 7, p. 1444, doi. 10.3390/v15071444
- By:
- Publication type:
- Article
Rapid response infrastructure for pandemic preparedness in a tertiary care hospital: lessons learned from the COVID-19 outbreak in Cologne, Germany, February to March 2020.
- Published in:
- Eurosurveillance (15607917), 2020, v. 25, n. 21, p. 6, doi. 10.2807/1560-7917.ES.2020.25.21.2000531
- By:
- Publication type:
- Article
Cross-Variant Neutralizing Serum Activity after SARS-CoV-2 Breakthrough Infections.
- Published in:
- Emerging Infectious Diseases, 2022, v. 28, n. 5, p. 1050, doi. 10.3201/eid2805.220271
- By:
- Publication type:
- Article
Repurposing QuantiFERON for Detection of Neutralizing Interferon-γ Autoantibodies in Patients With Nontuberculous Mycobacterial Infections.
- Published in:
- Clinical Infectious Diseases, 2017, v. 65, n. 3, p. 518, doi. 10.1093/cid/cix372
- By:
- Publication type:
- Article
First detection of a Mycobacterium tuberculosis XDR clinical isolate harbouring an RpoB I491F mutation in a Ukrainian patient treated in Germany, October 2023.
- Published in:
- Eurosurveillance (15607917), 2024, v. 29, n. 28, p. 1, doi. 10.2807/1560-7917.ES.2024.29.28.2400420
- By:
- Publication type:
- Article
Incidence and risk factors for HIV-tuberculosis coinfection in the Cologne–Bonn region: a retrospective cohort study.
- Published in:
- Infection, 2024, v. 52, n. 4, p. 1439, doi. 10.1007/s15010-024-02215-y
- By:
- Publication type:
- Article
Plasma interferon-γ-inducible protein 10 (IP-10) levels correlate with disease severity and paradoxical reactions in extrapulmonary tuberculosis.
- Published in:
- Infection, 2021, v. 49, n. 3, p. 437, doi. 10.1007/s15010-020-01541-1
- By:
- Publication type:
- Article
Intensified adjunctive corticosteroid therapy for CNS tuberculomas.
- Published in:
- Infection, 2020, v. 48, n. 2, p. 289, doi. 10.1007/s15010-019-01378-3
- By:
- Publication type:
- Article
Low prevalence of DHFR and DHPS mutations in Pneumocystis jirovecii strains obtained from a German cohort.
- Published in:
- Infection, 2017, v. 45, n. 3, p. 341, doi. 10.1007/s15010-017-1005-4
- By:
- Publication type:
- Article
Corticosteroids inhibit Mycobacterium tuberculosis-induced necrotic host cell death by abrogating mitochondrial membrane permeability transition.
- Published in:
- Nature Communications, 2019, v. 10, n. 1, p. 1, doi. 10.1038/s41467-019-08405-9
- By:
- Publication type:
- Article